Family · Pharmaceutical analytical standards
Valsartan
An angiotensin II receptor blocker (sartan) that relaxes blood vessels: patented in 1990 and in use since 1996 for high blood pressure, heart failure and after a heart attack. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?An amino acid hides in its molecule, valine: industrial synthesis starts from L-valine, onto which the biphenyl backbone typical of sartans is attached.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
